Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
3h
News-Medical.Net on MSNShingles vaccine cuts dementia risk by 20%, new study showsA large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
AUTOPOST on MSN13h
Why Audi Is Killing Its Own Logo to Survive in ChinaAudi, once a powerhouse in the Chinese market, boldly removes its iconic four-ring logo. This dramatic shift by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results